Answer:
No Change is expected on Stock value.
Explanation:
From the statement, it is evident that the EPS of $ 5 has been arrived at after factoring in the news about the FDA approval of the drug. This mere announcement was enough to raise the value of the company's EPS. For this reason, when the company releases its next earnings report, the price of the company's stock will not be change. This is because the news about FDA's approval of the drug was already absorbed.